HAM/TSP and ATL: Persistent paradoxes and new hypotheses

References

• Abdel-Hafiz H A, Heasley L E, et al. Activating transcription factor-2 DNA-binding activity is stimulated by phosphorylation catalyzed by p42 and p54 microtubule-associated protein kinases. Molec Endocrin 1992; 6: 2079–2089
   PubMedGoogle Scholar
• Abdel-Hafiz H A, Chen C Y, et al. Structural determinants outside of the leucine zipper influence the interactions of CREB and ATF-2: interaction of CREB with ATF-2 blocks Ela-ATF-2 complex formation. Oncogene 1993; 8: 1161–1171
   PubMedGoogle Scholar
• Altman R, Harrich D, et al. Human T-cell leukemia virus types I and II exhibit different DNase I protection patterns. J. Virol 1988; 62: 1339–1346
   PubMedGoogle Scholar
• Armstrong A P, Franklin A A, et al. Pleiotropic effect of the human transcription fractors. Proc Natl Acad Sci USA 1993; 90: 7303–7307
   PubMed Web of Science ®Google Scholar
• Bantignies F, Rousset R, et al. Characterization of the cellular proteins permitting transactivation of the HTLV-I promoter by Tax using a genetic approach in yeast. AIDS Res Hum Retrov 1995; 10: 216
   Google Scholar
• Baranger A M, Palmer C R, et al. Mechanism of DNA-binding enhancement by the human T-cell leukemia virus transactivator Tax. Nature 1995; 376: 606–608
   PubMed Web of Science ®Google Scholar
• Beimling P, Moelling K. Direct interaction of CREB protein with 21 bp Tax-response elements of HTLV-ILTR. Oncogene 1992; 7: 257–262
   PubMed Web of Science ®Google Scholar
• Bosselut R, Duvall J, et al. The product of the c-Ets 1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of the human T-cell leukemia virus HTLV-I. EMBO J 1990; 9: 3137–3144
   PubMed Web of Science ®Google Scholar
• Bosselut R, Lim F, et al. Myb protein binds to multiple sites in the human T-cell lymphotropic virus long terminal repeat of human T-cell leukemia virus 1 long terminal repeats and transactivates LTR-mediated expression. J. Virol 1992; 186: 764–769
   Google Scholar
• Brady J, Jeang K T, et al. Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat. J. Virol 1987; 67: 2175–2181
   Google Scholar
• Brown D A, Xu X, et al. Genomic footprinting of the HTLV-I LTR in a transgenic mouse tumorigenic model. Transgenics 1994; 1: 377–393
   Google Scholar
• Chattopadhayay S K, Sengupta D N, et al. Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice. J. Virol 1991; 65: 4232–4241
   Google Scholar
• Clark N M, Smith M J, et al. Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor. J. Virol 1993; 67(9)5522–5528
   Google Scholar
• Derse D, Mikovits J, et al. Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I gave rise to primary and secondary infections of T cells. J. Virol 1995; 69: 1907–1912
   PubMedGoogle Scholar
• Des Groseillers L, Rassart E, et al. Retrovirus-induced spongiform encephalopathy: the 3′-long terminal repeat-containing viral sequences influence the incidence of the disease and the specificity of the neurological syndrome. Proc Natl Acad Sci USA 1985; 82: 8818–8822
   Google Scholar
• Elovaara I, Koenig S, et al. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurologic disease. J Exp Med 1993; 177: 1567–1573
   Google Scholar
• Evangelista A, Maroushek S, et al. Nucleotide sequence analysis of a provirus derived from an individual with tropical spastic paraparesis. Microbial Pathogenesis 1990; 8: 259–278
   Google Scholar
• Feuer G, Fraser J K, et al. HTLV-1 infection of human hematopoietic progenitor cells: effects on differentiation in vitro and on thymopoiesis in vivo. Abstract in The Second West Coast Retrovirus Meating. p48. 1995
   Google Scholar
• Franklin A A, Kubik M F, et al. Transactivation by the human T-cell leukemia virus tax protein is mediated through enhanced binding of activating transcription factor 2 (ATF-2) response and cAMP element-binding protein (CREB). J. Biol Chem 1993; 268: 21225–21231
   PubMed Web of Science ®Google Scholar
• Furukawa Y, Osame M, et al. Human T-cell leukemia virus type-1 (HTLV-1) tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy of tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells. Blood 1995; 85: 1865–1879
   PubMed Web of Science ®Google Scholar
• Gartenhaus R B, Wong-Staal F, et al. The promoter of human T-cell leukemia virus type-I is repressed by the immediate-early gene region of human cytomegalovirus in primary blood. Blood 1991; 78: 2956–2961
   PubMedGoogle Scholar
• Gessain A, Barin F, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407–409
   PubMed Web of Science ®Google Scholar
• Giam G Z, Nerenberg M, et al. Expression of the complete human T-cell leukemia virus type I pX coding sequence as a functional protein in Escherichia coli. Proc Natl Acad Sci (USA) 1986; 83(19)7192–7196
   Google Scholar
• Giam C Z, Xu Y L. HTLV-I tax gene product activates transcription via pre-existing cellular factors and cAMP responsive element. J. Biol Chem 1989; 264(26)15236–15241
   Google Scholar
• Giraudon P, Bernard A, Malcus C, Dufay N, Desgranges C, Belin M F. Retroviral infection (HTLV-I) induces cytokine-regulated immunomodulation and cytotoxicity of medulloblastoma cells. Journal of Neuropathology & Experimental Neurology 1995; 54(2)165–174
   Google Scholar
• Gitlin S D, Bosselut R, et al. Sequence-specific interaction of the Etsl protein with the long terminal repeat of the human T-lymphotropic virus type I. Virol 1991; 65: 5513–5523
   Google Scholar
• Gonzalez-Dunia D, Chirinian-Syan S, et al. Functional analysis of two long terminal repeats from the HTLV-1 retroviruses. Gene 1992a; 161: 151–158
   Google Scholar
• Gonzalez-Dunia D, Grimber G, et al. Tissue expression pattern directed in transgenic mice by the LTR of an HTLV-1 provirus isolated from a case of tropical spastic paraparesis. Virol 1992b; 187: 705–710
   Google Scholar
• Gupta S, Campbell D, et al. Transcription factor ATF-2 regulation by the JNK signal transduction pathway. Science 1995; 267: 389–393
   PubMed Web of Science ®Google Scholar
• Hahn B, Gallo R C, et al. Clonal selection of human T-cell leukemia virus-infected cells in vivo and in vitro. Mol Biol Med 1984; 2(1)29–36
   Google Scholar
• Hamelin-Bourassa D, Skamene E, et al. Susceptibility to a mouse acquired immunodeficiency syndrome is influenced by the H-2. Immunogenetics 1989; 30(4)266–272
   Google Scholar
• Hara H, Morita M, et al. Detection of human T lymphotropic virus type 1 (HTLV-1) proviral DNA and analysis of T-cell receptor Vb˜ CDR3 sequences in spinal cord lesions of HTLV-1 associated myelopathy/tropical spastic paraparesis. J Exp Med 1994; 180: 381–839
   Google Scholar
• Ho D, Rota T, et al. Infection of human endothelial cells by human T lymphotropic virus type 1. Proc Natl Acad Sci USA 1984; 81: 7588–7590
   Google Scholar
• Hoxie J A, Matthews D M, et al. Infection of human endothelial cells by human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1984; 81(23)7591–7595
   Google Scholar
• Huang M, Simard C, et al. The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. J. Virol 1991; 65(12)6562–6571
   Google Scholar
• Ishiguro N, Abe M, et al. A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats. J. Exp Med 1992; 176(4)981–989
   Google Scholar
• Jacobson S, Shida H, et al. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 1990; 348(6298)245–248
   PubMed Web of Science ®Google Scholar
• Jeang K T, Boros I, et al. Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence. J. Virol 1988; 62(12)4499–4509
   Google Scholar
• Jolicoeur P, Gravel C, et al. Molecular Neurovirology. Humana Press. 1992; 199–244, Pathogenesis of murine spongiform myeloencephalopathy induced by a murine retrovirus. In Roos, RP (ed)
   Google Scholar
• Kannagi M, Matsushita S, et al. 1994; S54–59, Cytotoxic T cells response and expression of the target antigen in HTLV-I infection. Leukemia 8
   Google Scholar
• Kaplan J E, Osame M, et al. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J. Aquir Immune Defic Syndr 1990; 3: 1096–1101
   PubMed Web of Science ®Google Scholar
• Kashanchi F, Duvall J F, et al. Sequences downstream of the RNA initiation site regulate human T-cell lymphotropic virus type I basal gene expression. J. Virol 1993; 67: 2894–2902
   PubMedGoogle Scholar
• Kimata J T, Ratner L. Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type 1 mediated lymphocyte immortalization. Virol 1991; 65: 4398–4401
   Google Scholar
• Kimata J T, Wong F H, et al. Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. J. Virol 1994; 204(2)656–664
   Google Scholar
• Kinoshita T, Shimoyama M, et al. Detection of mRNA for the tax/rexl gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 5620–5624
   PubMed Web of Science ®Google Scholar
• Kitajima I, Shinohara T, et al. Ablation of transplanted HTLV-I tax mediated tumors in mice by antisense inhibition of NF-B. Science 1992; 258: 1792–1795
   PubMed Web of Science ®Google Scholar
• Komurian F, Pelloquin F, et al. In vitro genomic variability of human T-cell leukemia virus type 1 depends more on geography than upon pathologies. J. Virol 1991; 65: 3770–3778
   Google Scholar
• Koyanagi Y, Itoyama Y, et al. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virol 1993; 196(1)25–33
   Google Scholar
• Kubota R, Fujiyoshi T, et al. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I associated myelopathy. J. Neuroimmunol 1993; 42: 147–154
   Google Scholar
• Lehky T J, Fox C H, et al. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 1995; 37: 167–175
   PubMed Web of Science ®Google Scholar
• Lenz J, Celander D, et al. Determination of the leukemogenicity of a murine retrovirus by sequences within the long terminal repeat. Nature 1984; 308: 467–470
   PubMed Web of Science ®Google Scholar
• Low K G, Chu H M, et al. Novel interactions between human T-cell leukemia virus type I Tax and activating transcription factor 3 at a cyclic AMP-responsive element. Mol Cell Biol 1994; 14(7)4958–4974
   PubMedGoogle Scholar
• Macatonia S E, Cruickshank J K, et al. Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res Hum Retrov 1992; 8(9)1699–1706
   Google Scholar
• Maehama T, Nakayama M, et al. Studies on factor affecting mother to child HTLV-I transmission. Acta Obstetrica et Gynaecologica Japonica 1992; 44: 215–222
   Google Scholar
• Mahieux R, de Heg T, et al. The tax mutation at nucleotide 7959 of human T-cell leukemia virus type 1 (HTLV-1) is not associated with tropical spastic paraparesis/HTLV-1-associated myelopathy but is linked to the cosmopolitan molecular genotype [letter]. J. Virol 1995; 69(9)5925–5927
   Google Scholar
• Makino M, Morse H CHI, et al. H-2-associated and background genes influence the development of a murine retrovirus-induced immunodeficiency syndrome. J Immunol 1990; 144(11)4347–4355
   Google Scholar
• Migone T S, Lin J X, et al. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 1995; 269: 79–81
   PubMed Web of Science ®Google Scholar
• Miyai I, Saida T, et al. Familial cases of HTLV-I-associated myelopathy. Ann Neurol 1987; 22(5)601–605
   Google Scholar
• Muchardt C, Seeler J-S, et al. Regulation of HTLV-I gene expression by tax and AP-2. The New Biologist 1992; 4: 541–550
   PubMedGoogle Scholar
• Mukhopadhyaya R, Sadaie M. Nucleotide sequence analysis of HTLV-1 isolated from cerebrospinal fluid of a patient with TSP/HAM: comparison to other HTLV-1 isolates. ADDS Res Hum Retrov 1993; 9: 109–114
   Google Scholar
• Nagy K, Clapham P, et al. Human T cell leukemia virus type 1: Induction of syncytia and inhibition by patients' sera. Int J. Cancer 1983; 32: 321–328
   PubMedGoogle Scholar
• Nakamura M, Ohtani K, et al. Functional mapping of the activity of the R region in the human T-cell leukemia virus type I long terminal repeat to increase gene expression. Virus Genes 1989; 2: 147–155
   Google Scholar
• Nishimura M, McFarlin D E, et al. Sequence comparisons of HTLV-I from HAM/TSP patients and their asymptomatic spouses. Neurol 1993; 43: 2621–2624
   Google Scholar
• Nyborg J K, Matthews M A, et al. Interaction of host cell proteins with the human T-cell leukemia virus type I transcriptional control region, n. A comprehensive map of protein-binding sites facilitates construction of a simple chimeric promoter responsive to the viral tax2 gene product. J. Biol Chem 1990; 265(14)8237–8242
   Google Scholar
• Nyborg J K, Dynan W S. Interaction of cellular proteins with the human T-cell leukemia virus type I transcriptional control region. Purification of cellular proteins that bind the 21-base pair repeat elements. J. Biol Chem 1990; 265: 8230–8236
   PubMedGoogle Scholar
• Oki T, Yoshinaga M, et al. A sero-epidemiological study of mother-to-child transmission of HTLV-I in southern Kyushu. Asia-Oceania J Obstet Gyne 1992; 18: 371–377
   PubMedGoogle Scholar
• Oliff A, Signorelli K, et al. The envelope gene and long terminal repeat sequences contribute to the pathogenic phenotype of helper-independent Friend virus. J. Virol 1984; 51: 788–794
   PubMedGoogle Scholar
• Osame M, Usuku K, et al. HTLV-I associated myelopathy: a new clinical entity. Lancet 1986; 1: 1031–1032
   PubMed Web of Science ®Google Scholar
• Osame M, Janssen R, et al. Nationwide survey of HTLV-1 associated myelopathy in Japan association with blood transfusion. Ann Neurol 1990; 28: 50–56
   PubMed Web of Science ®Google Scholar
• Paskalis H, Felber B K, et al. Cis-acting sequences responsible for the transcriptional activation of human T-cell leukemia virus type I constitute a conditional enhancer. Proc Natl Acad Sci (USA) 1986; 83: 6558–6562
   PubMedGoogle Scholar
• Perini G, Wagner S, et al. Recognition of bZEP proteins by the human T-cell leukemia virus transactivator Tax. Nature 1995; 376: 602–605
   PubMed Web of Science ®Google Scholar
• Ratner L, Philpott T, et al. Nucleotide sequence analysis of human T-lymphotropic virus type 1 of diverse geographical origins. AIDS Res Hum Retrov 1991; 7: 923–941
   PubMed Web of Science ®Google Scholar
• Renjifo B, Borrero I, et al. Tax mutations associated with tropical spastic paraparesis/humaii T-cell leukemia virus type 1-associated myelopathy. J. Virol 1995; 69: 2611–2616
   Google Scholar
• Roman G C, Spencer P S, et al. Tropical spastic paraparesis in the Seychelles Islands: a clinical and case-control neuroepidemiolgic study. Neurol 1987; 37: 1323–1328
   Google Scholar
• Ruben S M, Perkins A, et al. Activation of NF-kappa B by the HTLV-I trans-activator protein Tax requires an additional factor present in lymphoid cells. New Biologist 1989; 1(3)275–284
   Google Scholar
• Saito M, Furukawa Y, et al. Frequent mutation in pX region of HTLV-1 is observed in HAM/TSP patients, but is not specifically associated with the central nervous system lesions. J. Neurovirol 1995; 1: 286–294
   Web of Science ®Google Scholar
• Sakai M, Eguchi K, et al. Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells. J. Clin Invest 1993; 92(4)1957–1966
   PubMed Web of Science ®Google Scholar
• Saksena N, Sherman M P, et al. LTR sequence and phylogenetic analyses of a newly discovered variant of HTLV-I isolated from the Hagahai of Papua New Guinea. Virol 1992; 189: 1–9
   Google Scholar
• Salazar-Grueso E F, Holzer T J, et al. Familial spastic paraparesis syndrome associated with HTLV-1 infection. New Engl J Med 1990; 323(11)732–737
   Google Scholar
• Seiki M, Hikikoshi A, et al. The U5 sequence is a cis-acting repressive element for genomic RNA expression of human T cell leukemia virus type 1. Virol 1990; 176: 81–86
   Google Scholar
• Setoyama M, Fujiyoshi T, et al. HTLV-1 messenger RNA is expressed in vivo in adult T cell leukemia/lymphoma patients: an in situ hybridization study. J. Int Cancer 1994; 57: 760–764
   Google Scholar
• Shimotohno K, Takano M, et al. Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription. Proc Natl Acad Sci (USA) 1986; 83(21)8112–8116
   Google Scholar
• Shinzato O, Kamihira S, et al. Relationship between the anti-HTLV-1 antibody level, the number of abnormal lymphocytes and the viral genome dose in HTLV-1-infected individuals. Int J Cancer 1993; 54: 208–212
   PubMed Web of Science ®Google Scholar
• Sinangil F, Harada S, et al. Host cell range of adult T cell leukemia virus. I. Viral infectivity and binding to various cells as detected by flow cytometry. Int J Cancer 1985; 36: 191–198
   PubMedGoogle Scholar
• Speck N A, Renjifo B, et al. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev 1990; 4: 543–550
   Google Scholar
• Sugamura K, Fujii M, et al. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer 1984; 34(2)221–228
   Google Scholar
• Sullivan M T, Williams A E, et al. Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). Arch Intern Med 1991; 151(10)2043–2048
   Google Scholar
• Stuver S O, Tachibana N, et al. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J. Infect Dis 1993; 167(1)57–65
   PubMed Web of Science ®Google Scholar
• Suzuki T, Fujisawa J I, et al. The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc Natl Acad Sci USA 1993; 90(2)610–614
   Google Scholar
• Tajima K, Kiroishi T. Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan. Jap J Clin Oncol 1985; 15: 423–430
   PubMed Web of Science ®Google Scholar
• Take H, Umemoto M, et al. Transmission routes of HTLV-I: an analysis of 66 families. Japanese J Cancer Rsch 1993; 84(12)1265–1267
   PubMedGoogle Scholar
• Takebe Y, Seiki M, et al. SRa promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol 1988; 8: 466–472
   PubMed Web of Science ®Google Scholar
• Tanimura A, Teshima H, et al. A new regulatory element that augments the Tax-dependent enhancer of human T-cell leukemia virus type 1 and cloning of cDNAs encoding its binding proteins. J. Virol 1993; 67(9)5375–5382
   Google Scholar
• Tendler C L, Greenberg S J, et al. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis. J. Cell Biochem 1991; 46: 302–311
   PubMedGoogle Scholar
• Tillmann M, Wessner R, et al. Identification of human T-cell lymphotropic virus type I 21-base-pair repeat-specific and glial cell-specific DNA-protein complexes. J. Virol 1994; 68(7)4597–4608
   Google Scholar
• Tochikura T, Iwahashi M, et al. Effect of human serum anti-HTLV antibodies on viral antigen induction in vitro cultured peripheral lymphocytes from adult T-cell leukemia patients and healthy virus carriers. Int J Cancer 1985; 36(1)1–7
   Google Scholar
• Trujillo J M, Cincha M, et al. Seroprevalence and cofactors of HTLV-I infection in Tumaoc, Colombia. AIDS Res Hum Retrov 1992; 8: 651–657
   Google Scholar
• Usuku K, Sonada S, et al. Immune responsiveness against HTLV-I in HTLV-1-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol 1988; 23S: 143–150
   Google Scholar
• Utz U, Koenig S, et al. Presentation of three different viral peptides, HTLV-I tax, HCMV gB, and influenza virus Ml is determined by common structural features of the HLA-A2.1 molecule. J. Immunol 1992; 149: 214–221
   Google Scholar
• Vidal A U, Gessain A, et al. Phylogenetic classification of human T cell leukemia/lymphoma virus type I genotypes in five major molecular and geographical subtypes. J. Gen Virol 1994; 75 (Pt 12): 3655–3666
   Google Scholar
• Wagner S, Green M R. HTLV-1 Tax protein stimulation of DNA binding by bZIP proteins enhancing dimerization. Science 1993; 265: 395–399
   Google Scholar
• Xu Y L, Adya N, et al. Cellular factors involved in transcription and Tax-mediated trans-activation directed by the TGACGT motifs in human T-cell leukemia virus type I promoter. J. Biol Chem 1990; 265(33)20285–20292
   Google Scholar
• Xu X, Brown D A, et al. Transcriptional suppression of the human T-cell leukemia virus type 1 long terminal repeat occurs by an unconventional interaction of a CREB factor with the R region. Mol Cell Biol 1994; 14: 5371–5383
   PubMedGoogle Scholar
• Xu X, Kang S H, et al. Constitutive activation of different Jak tyrosine kinases in Human T-cell leukemia virus type 1 (HTLV-1) tax protein or virus transformed cells. J. Clin Invest 1995; 96: 1548–1555
   PubMed Web of Science ®Google Scholar
• Xu X, Kang S H, et al. Sequence requirements of ATF2 and CREB binding to the Human T-cell leukemia virus type 1 (HTLV-1) LTR R region. Virology 1996; 1996, (in press)
   Google Scholar
• Yoshida M, Osame M, et al. Increased replication of HTLV-1 in HTLV-1-associated-myelopathy. Ann Neurol 1989; 26: 331–335
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Fujisawa J, et al. Multiple cDNA clones encoding nuclear proteins that bind to the tax-dependent enhancer of HTLV-1: all contain a leucine zipper structure and basic amino acid domain. EMBO J 1990; 9(8)2537–2542
   Google Scholar
• Zhao L J, Giam C Z. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc Natl Acad Sci USA 1992; 89(15)7070–7074
   PubMed Web of Science ®Google Scholar
• Zhao T M, Robinson M A, et al. Variation in HTLV-I sequences from rabbit cell lines with diverse in vivo effects. Virol 1993; 195: 271–274
   Google Scholar
• Zhao T M, Robinson M A, et al. Characterization of an infectious molecular clone of human T-cell leukemia virus type I. J. Virol 1995; 69(4)2024–2034
   Google Scholar